sacituzumab
gilead
['breast', 'tropics-02']
breast cancer research: final results of tropics-02 reported at #asco23. data shows antibody-drug conjugate offers significant survival benefit for patients with hr-positive/her2-negative metastatic breast cancer
read more cc: 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090